To validate the database findings, we analyzed in situ Rab1A expression in the tumor and para-tumor tissues of GC patients, and not only observed aberrantly high levels of Rab1A in the former, but also a significant correlation between its overexpression and worse 5-year survival. Here, RAB1A is linked to gastric cancer.